Director - Clinical Development (Medical Monitoring)
COMPANY BACKGROUND
Akero Therapeutics, a Novo Nordisk company, is a clinical stage biopharmaceutical company focused on discovering and developing transformational treatments for patients with serious metabolic diseases marked by high unmet need. Our current focus is on advancing our lead program efruxifermin (EFX) to provide a powerful new treatment for patients with MASH(metabolic dysfunction-associated steatohepatitis).
We are a team of problem solvers dedicated to pursuing bold scientific approaches to build a brighter future for patients. Our diverse skill sets and backgrounds, desire to learn from each other and collaborative spirit breed a culture where everyone feels inspired to bring their best thinking to work, and to bring out the best in others.
Reporting to the VP Clinical Development, the Director, Clinical Development will contribute to the execution of the Phase 3 clinical development programme for Efruxifermin (EFX). Key responsibilities include, but are not limited to clinical trial execution, medical monitoring, data analysis and reporting of results for regulatory submissions or scientific presentations and publications. They will be responsible for clinical guidance within the organization and will serve as a medical expert both internally and ext
